Absci (ABSI) Change in Account Payables (2020 - 2026)
Absci (ABSI) posted Change in Account Payables of -$2.0 million for Q1 2026, down 5613.51% sequentially from $37000.0 in Q4 2025, and up 6.46% YoY from -$1.9 million in Q1 2025.
Powered by 
Analysis
Absci (ABSI) Change in Account Payables (2020 - 2026) Analysis & Trends
Absci has reported Change in Account Payables for 7 years, with the latest figure at -$2.0 million in Q1 2026.
- Quarterly Change in Account Payables rose 6.46% year-over-year to -$2.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.2 million (up 305.83% YoY) and the FY2025 annual result came in at $1.1 million, down 36.8% from the prior year.
- Change in Account Payables eased to -$2.0 million in Q1 2026 per ABSI's latest filing, from $37000.0 in the prior quarter.
- Over five years, Change in Account Payables peaked at $6.8 million in Q2 2025 and troughed at -$3.6 million in Q3 2025.
- A 5-year average of -$31411.8 and a median of $22000.0 in 2022 frame the typical range for Change in Account Payables.
- The widest YoY moves for Change in Account Payables: up 16607.32% in 2025, down 11940.0% in 2025.
- Over 5 years, Change in Account Payables stood at $691000.0 in 2022, then sank by 158.76% to -$406000.0 in 2023, then soared by 486.7% to $1.6 million in 2024, then tumbled by 97.64% to $37000.0 in 2025, then sank by 5613.51% to -$2.0 million in 2026.
- According to Business Quant data, Change in Account Payables over the past three periods registered -$2.0 million, $37000.0, and -$3.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.43 Bn | 130.58 Bn | 2.84 Bn | -66.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.34 Bn | 58.15 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.98 Bn | 52.85 Bn | 52.00 Mn | -8.00 Mn |
| 5 | Revolution Medicines | 43.98 Bn | 43.98 Bn | - | 5.03 Mn |
| 6 | BeOne Medicines | 39.92 Bn | 34.82 Bn | 1.53 Bn | 37.53 Mn |
| 7 | Alnylam Pharmaceuticals | 35.42 Bn | 32.11 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - | - |
| 9 | Insmed | 27.36 Bn | 26.20 Bn | 358.27 Mn | - |
| 10 | Absci | 1.38 Bn | 1.18 Bn | - | -1.05 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.05 Mn |
| Mar 31, 2026 | -2.04 Mn |
| Dec 31, 2025 | 37,000.00 |
| Sep 30, 2025 | -2.25 Mn |
| Jun 30, 2025 | 5.49 Mn |
| Mar 31, 2025 | -2.18 Mn |
| Dec 31, 2024 | 1.57 Mn |
| Sep 30, 2024 | -30,000.00 |
| Jun 30, 2024 | 41,000.00 |
| Mar 31, 2024 | 150,000.00 |
| Dec 31, 2023 | -406,000.00 |
| Sep 30, 2023 | 505,000.00 |
| Jun 30, 2023 | -403,000.00 |
| Mar 31, 2023 | -482,000.00 |
| Dec 31, 2022 | 691,000.00 |
| Sep 30, 2022 | -1.88 Mn |
| Jun 30, 2022 | 22,000.00 |
| Mar 31, 2022 | 637,000.00 |
| Dec 31, 2021 | 29,000.00 |
| Sep 30, 2021 | -1.20 Mn |